研究
2020 研究業績・論文発表
論文
T. Fujino, K. Suda and T. Mitsudomi
Emerging MET tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
Expert Opin Emerg Drugs (2020) 25: 229-249.
S. Ohara, K. Suda, K. Sakai, M. Nishino, M. Chiba, M. Shimoji, T. Takemoto, T. Fujino, T. Koga, A. Hamada, J. Soh, K. Nishio and T. Mitsudomi
Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study
Transl Lung Cancer Res (2020) 9: 1915-1923.
S. Ohara, K. Suda, K. Tomizawa, T. Takemoto, T. Fujino, A. Hamada, T. Koga, M. Nishino, M. Chiba, K. Sato, M. Shimoji, J. Soh and T. Mitsudomi
Prognostic value of plasma fibrinogen and D-dimer levels in patients with surgically resected non-small cell lung cancer
Surg Today (2020) 50: 1427-1433.
K. Suda and T. Mitsudomi
Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy
Transl Lung Cancer Res (2020) 9: 2618-2628.
K. Suda and T. Mitsudomi
Inter-tumor heterogeneity of PD-L1 status: is it important in clinical decision making?
J Thorac Dis (2020) 12: 1770-1775.
K. Suda, I. Murakami, K. Obata, K. Sakai, T. Fujino, T. Koga, S. Ohara, A. Hamada, J. Soh, K. Nishio and T. Mitsudomi
Spatial heterogeneity of acquired resistance mechanisms to 1st/2nd generation EGFR tyrosine kinase inhibitors in lung cancer
Lung Cancer (2020) 148: 100-104.